BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 18063674)

  • 1. Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus.
    Nikpour M; Dempsey AA; Urowitz MB; Gladman DD; Barnes DA
    Ann Rheum Dis; 2008 Aug; 67(8):1069-75. PubMed ID: 18063674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association between the interferon-alpha signature and longitudinal changes in disease activity in systemic lupus erythematosus.
    Landolt-Marticorena C; Bonventi G; Lubovich A; Ferguson C; Unnithan T; Su J; Gladman DD; Urowitz M; Fortin PR; Wither J
    Ann Rheum Dis; 2009 Sep; 68(9):1440-6. PubMed ID: 18772188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Feng X; Wu H; Grossman JM; Hanvivadhanakul P; FitzGerald JD; Park GS; Dong X; Chen W; Kim MH; Weng HH; Furst DE; Gorn A; McMahon M; Taylor M; Brahn E; Hahn BH; Tsao BP
    Arthritis Rheum; 2006 Sep; 54(9):2951-62. PubMed ID: 16947629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
    Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK
    Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interferon-inducible genes lymphocyte antigen 6 complex E and tetratricopeptide repeats 1 are correlated with clinical features of patients with systemic lupus erythematosus].
    Tang JP; Gu YY; Shen N; Ye S; Qian J; Hua J; Chen XG; Chen SL; Bao CD; Wang Y; Zhang W
    Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1157-60. PubMed ID: 15387975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus.
    Biesen R; Demir C; Barkhudarova F; Grün JR; Steinbrich-Zöllner M; Backhaus M; Häupl T; Rudwaleit M; Riemekasten G; Radbruch A; Hiepe F; Burmester GR; Grützkau A
    Arthritis Rheum; 2008 Apr; 58(4):1136-45. PubMed ID: 18383365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein interaction for an interferon-inducible systemic lupus associated gene, IFIT1.
    Ye S; Pang H; Gu YY; Hua J; Chen XG; Bao CD; Wang Y; Zhang W; Qian J; Tsao BP; Hahn BH; Chen SL; Rao ZH; Shen N
    Rheumatology (Oxford); 2003 Oct; 42(10):1155-63. PubMed ID: 12777642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray.
    Han GM; Chen SL; Shen N; Ye S; Bao CD; Gu YY
    Genes Immun; 2003 Apr; 4(3):177-86. PubMed ID: 12700592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shared and unique gene expression in systemic lupus erythematosus depending on disease activity.
    Sandrin-Garcia P; Junta CM; Fachin AL; Mello SS; Baião AM; Rassi DM; Ferreira MC; Trevisan GL; Sakamoto-Hojo ET; Louzada-Júnior P; Passos GA; Donadi EA
    Ann N Y Acad Sci; 2009 Sep; 1173():493-500. PubMed ID: 19758191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus.
    Nzeusseu Toukap A; Galant C; Theate I; Maudoux AL; Lories RJ; Houssiau FA; Lauwerys BR
    Arthritis Rheum; 2007 May; 56(5):1579-88. PubMed ID: 17469140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of immunosuppressive therapy on the messenger RNA expression of target genes in the urinary sediment of patients with active lupus nephritis.
    Chan RW; Lai FM; Li EK; Tam LS; Chow KM; Li PK; Szeto CC
    Nephrol Dial Transplant; 2006 Jun; 21(6):1534-40. PubMed ID: 16449281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus.
    Kirou KA; Lee C; George S; Louca K; Papagiannis IG; Peterson MG; Ly N; Woodward RN; Fry KE; Lau AY; Prentice JG; Wohlgemuth JG; Crow MK
    Arthritis Rheum; 2004 Dec; 50(12):3958-67. PubMed ID: 15593221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gene expression profiling of peripheral leukocytes from patients with systemic lupus erythematosus using oligonucleotide DNA microarray].
    Wu YS; Fan RQ; Chen DC; Xuan GW
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):929-34. PubMed ID: 16109543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling in the study of the pathogenesis of systemic lupus erythematosus.
    Qing X; Putterman C
    Autoimmun Rev; 2004 Nov; 3(7-8):505-9. PubMed ID: 15546798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
    Uribe AG; Vilá LM; McGwin G; Sanchez ML; Reveille JD; Alarcón GS
    J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic lupus erythematosus disease activity index 2000.
    Gladman DD; Ibañez D; Urowitz MB
    J Rheumatol; 2002 Feb; 29(2):288-91. PubMed ID: 11838846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and expression profiling of genes upregulated in the peripheral blood cells of systemic lupus erythematosus patients.
    Ishii T; Onda H; Tanigawa A; Ohshima S; Fujiwara H; Mima T; Katada Y; Deguchi H; Suemura M; Miyake T; Miyatake K; Kawase I; Zhao H; Tomiyama Y; Saeki Y; Nojima H
    DNA Res; 2005; 12(6):429-39. PubMed ID: 16769699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway.
    Higgs BW; Liu Z; White B; Zhu W; White WI; Morehouse C; Brohawn P; Kiener PA; Richman L; Fiorentino D; Greenberg SA; Jallal B; Yao Y
    Ann Rheum Dis; 2011 Nov; 70(11):2029-36. PubMed ID: 21803750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling in peripheral blood mononuclear cells from lupus patients with active and inactive disease.
    Rus V; Chen H; Zernetkina V; Magder LS; Mathai S; Hochberg MC; Via CS
    Clin Immunol; 2004 Sep; 112(3):231-4. PubMed ID: 15308115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
    Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.